New precision medicine platform for menopause launches in the US

A women-led telemedicine platform focused on menopause care has officially launched in the US.

FemGevity aims to offer women a more holistic approach to menopause care, in contrast to the “one-size-fits-all” mentality that has done little to help women struggling with symptoms.

Menopause is a significant health issue affecting over one million women annually in the United States.

But despite the diverse ways it can affect women, care and treatment have been standardised, argues FemGevity.

The current approach, the company says, fails to consider that women experience menopause differently and have unique needs.

“We are no longer asking the question: ‘How do I manage this chronic disease?’ We are changing the narrative to ‘is my health optimal for my age?’,” says Kristin Mallon, co-founder, and CEO of FemGevity.

“Just because your lab values are normal doesn’t mean they are optimal. At FemGevity, we are optimising health for women at any age, including menopause and beyond.”

The platform aims to make precision medicine services available and affordable to all women, “levelling the playing field” and making healthcare accessible to more people.

The company says this would involve personalised one-on-one consultations with doctors, laboratory testing and analysis as well as longevity retention plans.

“At FemGevity, we recognise the unique challenges and experiences faced by women of colour during this time, and we’re committed to providing personalised resources and support to help them take control of their health and well-being,” explains Dr Rachel Villanueva, a medical advisor at FemGevity.

“Our approach allows patients and doctors to collaborate and tailor treatment plans to meet specific needs.”

Michele Wispelwey, co-founder and president of FemGevity, says: “Empowering women to be confident in this transitional period in their lives and encouraging the medical community to focus on feminine longevity to develop more effective treatments and interventions to help women navigate this transition smoothly is our ultimate goal.”